11.7 C
Munich
Friday, May 15, 2026

“Innovative Hormone Drug Shortens Calving Season”

Must read

A breakthrough innovation from the University of Saskatchewan could potentially reduce the duration of the calving season, a demanding period for beef producers. The discovery involves the adaptation of Cetrorelix, a hormone drug commonly used in human in vitro fertilization (IVF), for use in cattle breeding. Dr. Jaswant Singh, a veterinarian and researcher at the university’s Western College of Veterinary Medicine, along with graduate students Dylan Farmer and Carlos Leonardi, spearheaded this development.

Having tested the drug on 200 cows with successful results, Dr. Singh expressed enthusiasm about its prospects for the future market. Cetrorelix functions as an ovulation synchronization method, facilitating rapid impregnation of cows through IVF, leading to synchronized birthing periods among the cattle.

While various synchronization methods exist, Cetrorelix shows great promise in potentially becoming the most effective option. By shortening the calving period from two months to one, labor costs can be reduced, and animal management can be significantly improved, as highlighted by Dr. Singh.

Garner Deobald, a beef rancher and marketing manager at BoviGen Genetic Services, the leading bovine reproduction center in Saskatchewan, expressed keen interest in integrating Cetrorelix into their breeding practices, emphasizing the potential benefits for cattle reproduction and genetic management.

Moreover, the utilization of Cetrorelix could enhance artificial insemination as a preferred breeding method, offering insights into herd genetics and calf expectations. Dr. Singh mentioned that the university has pursued a patent for the drug and is collaborating with pharmaceutical companies to bring it to market.

The potential widespread adoption of Cetrorelix, coupled with its affordability and regulatory progress, hints at a transformative impact on cattle breeding practices globally. The drug’s efficacy in animals and its alignment with industry needs suggest a promising future for artificial insemination and enhanced breeding techniques.

More articles

Latest article